| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/09/2009 | WO2009086003A1 Methods for the treatment of gout |
| 07/09/2009 | WO2009085920A1 Fdf03 antibodies and uses thereof |
| 07/09/2009 | WO2009085765A1 Crystallization of anti-cd20 antibodies |
| 07/09/2009 | WO2009085475A1 Method for detection and treatment of aneurysms |
| 07/09/2009 | WO2009085383A1 Anti-human cytomegalovirus antibodies |
| 07/09/2009 | WO2009085209A2 Methods for using and identifying modulators of delta-like 4 |
| 07/09/2009 | WO2009085200A2 Anti-amyloid antibodies and uses thereof |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084481A1 Immunodetection assay for mycobacterium tuberculosis complex |
| 07/09/2009 | WO2009084369A1 Reagent for detecting hiv-1 antigen and detection method |
| 07/09/2009 | WO2009083602A1 B-cell depleting agents, like anti-cd20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 07/09/2009 | WO2009083246A1 Antibodies to tnf alpha |
| 07/09/2009 | WO2009083009A2 Monoclonal antibodies against cd32b |
| 07/09/2009 | WO2009067660A3 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 07/09/2009 | WO2009060418A3 Transgenic plants and modulators for improved stress tolerance |
| 07/09/2009 | WO2009037297A3 Method for the preparation of new oligoclonal antibodies |
| 07/09/2009 | WO2009033670A8 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 07/09/2009 | WO2009023184A3 Universal fibronectin type iii binding-domain libraries |
| 07/09/2009 | WO2009020933A9 Therapeutic use of anti-tweak receptor antibodies |
| 07/09/2009 | WO2008154251A4 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 07/09/2009 | WO2008141511A8 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF |
| 07/09/2009 | WO2008132134A9 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 07/09/2009 | WO2008054431A3 Anti-hyperproliferative therapies targeting hdgf |
| 07/09/2009 | WO2008000186A8 A method for identifying novel gene and the resulting novel genes |
| 07/09/2009 | WO2007098548A8 A molecule and chimeric molecules thereof |
| 07/09/2009 | WO2007098547A8 A molecule and chimeric molecules thereof |
| 07/09/2009 | US20090178151 guinea pig DP receptor |
| 07/09/2009 | US20090178146 Regulators of NFAT |
| 07/09/2009 | US20090176966 Natural IGM Antibodies and Inhibitors Thereof |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176724 Methods and Compositions for the Diagnosis, Prognosis and Treatment of Cancer |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176657 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
| 07/09/2009 | US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide |
| 07/09/2009 | US20090176254 Mammalian galanin receptors |
| 07/09/2009 | US20090176246 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 07/09/2009 | US20090176243 Novel monkey GPR103 and monkey QRFP and method of evaluating compound by using GPR103 |
| 07/09/2009 | US20090176238 Cynomolgus Toll-Like Receptor 3 |
| 07/09/2009 | US20090176235 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/09/2009 | US20090176223 Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Immune Disorders Using Galectin-1 |
| 07/09/2009 | US20090176217 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 07/09/2009 | US20090176209 Selection |
| 07/09/2009 | US20090176205 Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna |
| 07/09/2009 | US20090175923 Humanized anti-amyloid beta antibodies |
| 07/09/2009 | US20090175903 Measles subunit vaccine |
| 07/09/2009 | US20090175887 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/09/2009 | US20090175886 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues |
| 07/09/2009 | US20090175884 Misfolded proteins in cancer treatment and diagnosis |
| 07/09/2009 | US20090175883 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 07/09/2009 | US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders |
| 07/09/2009 | US20090175880 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 07/09/2009 | US20090175878 Cerebral Vasospasm Inhibitor |
| 07/09/2009 | US20090175877 Methods of inhibiting metastasis |
| 07/09/2009 | US20090175876 Methods of using phhla2 to co-stimulate t-cells |
| 07/09/2009 | US20090175875 Molecules and Methods for Modulating Complement Component |
| 07/09/2009 | US20090175873 Inhibiting tumor cell invasion, metastasis and angiogenesis |
| 07/09/2009 | US20090175871 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors |
| 07/09/2009 | US20090175870 Ykl-40 monoclonal authority |
| 07/09/2009 | US20090175867 Single-Chain Multivalent Binding Proteins with Effector Function |
| 07/09/2009 | US20090175865 using antibodies and antibody-drug conjugate compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions; killing or inhibiting the proliferation of tumor cells or cancer cells |
| 07/09/2009 | US20090175863 Agents targeting cd138 and uses thereof |
| 07/09/2009 | US20090175862 Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents |
| 07/09/2009 | US20090175861 Use of a b-cell-depleting antibody for treatment of polyoma virus infections |
| 07/09/2009 | US20090175860 Compositions and Methods of Use for Antibodies of c-Met |
| 07/09/2009 | US20090175859 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 07/09/2009 | US20090175858 Crystalline EGFR - matuzumab complex and matuzumab mimetics obtained thereof |
| 07/09/2009 | US20090175857 Human Antibodies That Bind Human IL-12 And Methods For Producing |
| 07/09/2009 | US20090175855 Novel compositions and methods for the treatment of immune related diseases |
| 07/09/2009 | US20090175851 Bivalent, bispecific antibodies |
| 07/09/2009 | US20090175850 NOGO Receptor Homologs |
| 07/09/2009 | US20090175847 Humanized antibodies to ab (20-42) globulomer and uses thereof |
| 07/09/2009 | US20090175844 Method of diagnosing bladder cancer |
| 07/09/2009 | US20090175823 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 07/09/2009 | US20090175796 Antibodies and related molecules that bind to 24p4c12 proteins |
| 07/09/2009 | US20090175791 Anti-VEGF Antibody Compositions and Methods |
| 07/09/2009 | US20090175789 Antibody raised against the ldl receptor |
| 07/09/2009 | US20090175784 Anti-Alpha V Immunoliposome Composition, Methods, and Uses |
| 07/09/2009 | CA2710984A1 Treatment and prophylaxis of amyloidosis |
| 07/09/2009 | CA2710761A1 Anti-t. cruzi antibodies and methods of use |
| 07/09/2009 | CA2710760A1 Cynomolgus toll-like receptor 3 |
| 07/09/2009 | CA2710252A1 Methods for the treatment of gout |
| 07/09/2009 | CA2710082A1 Methods for using and identifying modulators of delta-like 4 |
| 07/09/2009 | CA2709399A1 Anti-hedgehog antibodies |
| 07/09/2009 | CA2709354A1 Anti-amyloid antibodies and uses thereof |
| 07/09/2009 | CA2708951A1 Crystallization of anti-cd20 antibodies |
| 07/09/2009 | CA2708648A1 Fdf03 antibodies and uses thereof |
| 07/09/2009 | CA2707791A1 Therapy of rituximab-refractory rheumatoid arthritis patients |
| 07/09/2009 | CA2706899A1 B-cell depleting agents, like anti-cd20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 07/09/2009 | CA2703997A1 Fc variants with altered binding to fcrn |
| 07/08/2009 | EP2077325A1 Monoclonal antibody and use thereof |
| 07/08/2009 | EP2077324A2 Genes encoding proteolytic enzymes from aspargilli |
| 07/08/2009 | EP2077282A2 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 07/08/2009 | EP2077281A1 Anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 07/08/2009 | EP2077280A2 Anti-Carbohydrate Deficient Transferrin (CDT) specific antibodies, their production and use |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077276A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogensis |
| 07/08/2009 | EP2077275A2 IgA nephropathy-related DNA |
| 07/08/2009 | EP2077121A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder |
| 07/08/2009 | EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |